Pharmaceutical

& Healthcare

Pharmaceutical

Medical Technology

Biopharmaceutical

Our perspective

The pharmaceutical sector is facing a unique set of challenges: regulatory pressure, accelerated innovation cycles, and rising sustainability expectations. To stay competitive, companies must strike the right balance between performance, agility, and cost control.

At OPEO, we believe in a transformational approach that directly addresses the realities of R&D and industrialization — spanning research, development, and manufacturing.
Today more than ever, success depends on the ability to innovate, adapt operating models, and execute at speed.

Our mission: To help life sciences companies rise to these challenges while strengthening both their competitiveness and their positive impact.

Book a meeting with an expert

Paul Bobin - OPEO

Paul Bobin

Principal

Our areas of expertise

We support transformation across the entire value chain, delivering lasting and measurable impact. Our solutions are co-designed with your teams to ensure ownership, relevance, and long-term success.

Operational performance

We support site-level performance recovery across all stages of production,  including bulk, filling, and packaging, as well as support functions such as supply chain, quality control, quality assurance, engineering, and maintenance. We also address cross-functional processes like batch release, change control, and deviation management.

Our areas of expertise

We support transformation across the entire value chain, delivering lasting and measurable impact. Our solutions are co-designed with your teams to ensure ownership, relevance, and long-term success.

Operational performance

We support site-level performance recovery across all stages of production,  including bulk, filling, and packaging, as well as support functions such as supply chain, quality control, quality assurance, engineering, and maintenance. We also address cross-functional processes like batch release, change control, and deviation management.

Industrial strategy

We help reshape industrial footprints and restore site-level profitability through comprehensive programs. These include optimized Target Operating Models, technology-specific benchmarking, leadership coaching, and the identification of key levers across functions and business processes.

Digital & data

We implement AI, digital factory tools, and robotic process automation (RPA) to streamline workflows, optimize end-to-end processes, and reduce manual workload through automation.

Supply chain transformation

We redesign S&OP processes, decoupling strategies, and production planning frameworks to build more agile, resilient, and high-performing supply chains.

R&D and ramp-up

We optimize critical R&D workflows, from clinical trials to raw material management and clinical batch production. Our approach includes stronger project governance, the deployment of scalable operating and organizational models, and the implementation of operational excellence systems tailored to the needs of R&D and fast-paced industrial ramp-ups.

Our references

Human health – Vaccine development

Context: A company developing new vaccines was facing critical delays in clinical trial timelines.

Our approach:

  • Conducted a comprehensive diagnostic of R&D processes
  • Introduced agile trial management practices and coached transformation teams

Impact:

  • Significant reduction in clinical trial cycle times
  • Stronger alignment around a clear target operating model

Animal health – Bulk production optimization

Context: A bulk production site was experiencing inefficiencies in its manufacturing flows.

Our approach:

  • Assessed performance and optimized production sequencing
  • Reorganized teams and fine-tuned CAPEX/OPEX investment planning

Impact: Notable increase in throughput and reduced production waste

Medical devices – Supply chain transformation

Context: A company in the medical device sector needed to strengthen supply chain resilience while reducing operational costs.

Our approach:

  • Fully redesigned S&OP processes and implemented a postponement strategy
  • Optimized stock levels and logistics flows

Impact: Improved service levels and overall network performance

Biotech CDMO – Cost reduction initiative

Context: A biotech CDMO needed to improve cost control to support its growth strategy.

Our approach:

  • Performed a deep dive on direct and indirect cost drivers
  • Deployed RPA and digital tools across critical processes

Impact: Significant reduction in operating costs and improved profitability

Our team

A team of multidisciplinary experts, blending technical excellence with strategic insight. They translate your goals into actionable results, while adapting to the specificities of your organization.

We also leverage a network of senior partners from the pharmaceutical industry to support high-impact strategic and operational projects.

Paul Bobin - OPEO

Paul Bobin

Principal

LinkedIn
Arnaud BOUYSSIERE - OPEO

Arnaud BOUYSSIÈRE

Project Manager

LinkedIn
Clement Niessen - OPEO

Clément Niessen

Partner

LinkedIn

Frédéric SANDEI

Partner and founder

LinkedIn